Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation
View ORCID ProfileMichael B. Hall, View ORCID ProfileMarie Sylvianne Rabodoarivelo, View ORCID ProfileAnastasia Koch, View ORCID ProfileAnzaan Dippenaar, Sophie George, View ORCID ProfileMelanie Grobbelaar, View ORCID ProfileRobin Warren, View ORCID ProfileTimothy Walker, View ORCID ProfileHelen Cox, View ORCID ProfileSebastien Gagneux, Derrick Crook, Tim Peto, Niaina Rakotosamimanana, Simon Grandjean Lapierre, View ORCID ProfileZamin Iqbal
doi: https://doi.org/10.1101/2022.03.04.22271870
Michael B. Hall
1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, United Kingdom
Marie Sylvianne Rabodoarivelo
2Mycobacteriology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar
Anastasia Koch
3SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit & DST/NRF Centre of Excellence for Biomedical TB Research, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
4Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Anzaan Dippenaar
5Department of Science and Innovation-National Research Foundation Centre for Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
6Tuberculosis Omics Research Consortium, Family Medicine and Population Health, Institute of Global Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
Sophie George
7Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford University, Oxford, United Kingdom
Melanie Grobbelaar
5Department of Science and Innovation-National Research Foundation Centre for Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
Robin Warren
5Department of Science and Innovation-National Research Foundation Centre for Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa
Timothy Walker
8Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam
Helen Cox
4Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
9Division of Medical Microbiology, Department of Pathology, University of Cape Town
10Wellcome Centre for Infectious Disease Research in Africa, University of Cape Town
Sebastien Gagneux
11Swiss Tropical and Public Health Institute, Basel Switzerland
12University of Basel, Basel, Switzerland
Derrick Crook
7Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford University, Oxford, United Kingdom
Tim Peto
7Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford University, Oxford, United Kingdom
Niaina Rakotosamimanana
2Mycobacteriology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar
Simon Grandjean Lapierre
2Mycobacteriology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar
13Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montréal, Québec, Canada
14Immunopathology Axis, Centre de Recherche du Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada
Zamin Iqbal
1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, United Kingdom
Data Availability
All data produced in the present work are contained in the manuscript
Posted March 08, 2022.
Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation
Michael B. Hall, Marie Sylvianne Rabodoarivelo, Anastasia Koch, Anzaan Dippenaar, Sophie George, Melanie Grobbelaar, Robin Warren, Timothy Walker, Helen Cox, Sebastien Gagneux, Derrick Crook, Tim Peto, Niaina Rakotosamimanana, Simon Grandjean Lapierre, Zamin Iqbal
medRxiv 2022.03.04.22271870; doi: https://doi.org/10.1101/2022.03.04.22271870
Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation
Michael B. Hall, Marie Sylvianne Rabodoarivelo, Anastasia Koch, Anzaan Dippenaar, Sophie George, Melanie Grobbelaar, Robin Warren, Timothy Walker, Helen Cox, Sebastien Gagneux, Derrick Crook, Tim Peto, Niaina Rakotosamimanana, Simon Grandjean Lapierre, Zamin Iqbal
medRxiv 2022.03.04.22271870; doi: https://doi.org/10.1101/2022.03.04.22271870
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2942)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2916)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4353)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6937)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)